NasdaqCM - Nasdaq Real Time Price USD
Plus Therapeutics, Inc. (PSTV)
At close: 4:00 PM EDT
After hours: 5:21 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
--
--
--
--
303.0000
--
Operating Expense
14,105.0000
13,321.0000
19,712.0000
12,426.0000
9,887.0000
--
Operating Income
-14,105.0000
-13,321.0000
-19,712.0000
-12,426.0000
-9,584.0000
--
Net Non Operating Interest Income Expense
-3,387.0000
5.0000
-564.0000
-913.0000
-1,057.0000
--
Other Income Expense
--
--
1.0000
-60.0000
2,400.0000
2,174.0000
Pretax Income
-13,230.0000
-13,316.0000
-20,275.0000
-13,399.0000
-8,241.0000
--
Net Income Common Stockholders
-13,230.0000
-13,316.0000
-20,275.0000
-13,399.0000
-8,241.0000
--
Diluted NI Available to Com Stockholders
-13,230.0000
-13,316.0000
-20,275.0000
-13,399.0000
-8,241.0000
--
Basic EPS
-2.79
-4.24
-11.55
-16.65
-27.90
--
Diluted EPS
-3.09
-4.24
-11.55
-16.65
-27.90
--
Basic Average Shares
4,639.0060
3,140.9250
1,750.3500
805.9450
295.1890
--
Diluted Average Shares
5,699.5280
3,140.9250
1,750.3500
805.9450
295.1890
--
Total Operating Income as Reported
-14,105.0000
-13,321.0000
-19,712.0000
-12,492.0000
-9,584.0000
--
Total Expenses
14,105.0000
13,321.0000
19,712.0000
12,426.0000
9,887.0000
--
Net Income from Continuing & Discontinued Operation
-13,230.0000
-13,316.0000
-20,275.0000
-13,399.0000
-8,241.0000
--
Normalized Income
-17,492.0000
-13,316.0000
-20,275.0000
-13,339.0000
-10,641.0000
--
Interest Income
368.0000
400.0000
147.0000
19.0000
50.0000
--
Interest Expense
3,755.0000
395.0000
711.0000
932.0000
1,107.0000
--
Net Interest Income
-3,387.0000
5.0000
-564.0000
-913.0000
-1,057.0000
--
EBIT
-9,475.0000
-12,921.0000
-19,564.0000
-12,467.0000
-7,134.0000
--
EBITDA
-8,834.0000
-12,293.0000
-18,945.0000
-12,072.0000
-6,768.0000
--
Reconciled Depreciation
641.0000
628.0000
619.0000
395.0000
366.0000
--
Net Income from Continuing Operation Net Minority Interest
-13,230.0000
-13,316.0000
-20,275.0000
-13,399.0000
-8,241.0000
--
Total Unusual Items Excluding Goodwill
4,262.0000
--
1.0000
-60.0000
2,400.0000
2,174.0000
Total Unusual Items
4,262.0000
--
1.0000
-60.0000
2,400.0000
2,174.0000
Normalized EBITDA
-13,096.0000
-12,293.0000
-18,945.0000
-12,012.0000
-9,168.0000
--
12/31/2019 - 7/11/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALRN Aileron Therapeutics, Inc.
3.6700
+2.80%
PHIO Phio Pharmaceuticals Corp.
3.1300
+0.32%
ATHE Alterity Therapeutics Limited
1.2000
-2.44%
CNTX Context Therapeutics Inc.
2.0000
-2.91%
ARTL Artelo Biosciences, Inc.
1.2200
-2.40%
NBY NovaBay Pharmaceuticals, Inc.
0.5910
-4.85%
PALI Palisade Bio, Inc.
3.7000
-5.37%
NRBO NeuroBo Pharmaceuticals, Inc.
2.8800
-0.69%
UBX Unity Biotechnology, Inc.
1.4000
0.00%
RLMD Relmada Therapeutics, Inc.
3.6400
+0.28%